Befunolol
Befunolol (INN) is a beta blocker with intrinsic sympathomimetic activity used in the management of open-angle glaucoma. It also acts as a β adrenoreceptor partial agonist. Befunolol was introduced in Japan in 1983 by Kakenyaku Kako Co. under the trade name Bentos.
Wikipage redirect
primaryTopic
Befunolol
Befunolol (INN) is a beta blocker with intrinsic sympathomimetic activity used in the management of open-angle glaucoma. It also acts as a β adrenoreceptor partial agonist. Befunolol was introduced in Japan in 1983 by Kakenyaku Kako Co. under the trade name Bentos.
has abstract
Befunolol (INN) is a beta bloc ...... . under the trade name Bentos.
@en
Il befunololo, spesso commerci ...... lo 0,50% di principio attivo.
@it
ATC prefix
ATC suffix
CAS number
39552-01-7
DrugBank
FDA UNII code
418546MT3A
IUPAC name
(RS)-1-{7-[2-hydroxy-3-(propan-2-ylamino)propoxy]- 1-benzofuran-2-yl}ethanone
@en
PubChem
thumbnail
Wikipage page ID
13,379,842
Wikipage revision ID
731,736,104
ChEMBL
ChemSpiderID
molecular weight
2.91342e+2
StdInChIKey
ZPQPDBIHYCBNIG-UHFFFAOYSA-N
tradename
Benfuran, Bentos, Betaclar, Glauconex
Verifiedfields
verifiedrevid
413,883,923
Watchedfields
hypernym
comment
Befunolol (INN) is a beta bloc ...... . under the trade name Bentos.
@en
Il befunololo, spesso commerci ...... lo 0,50% di principio attivo.
@it
label
Befunolol
@en
Befunololo
@it